Dashboard
Manage Tickers

CCXIChemoCentryx, Inc.

Nasdaq www.chemocentryx.com


$ 52.00 $ 0.03 (0.06 %)    

Wednesday, 19-Oct-2022 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 51.99
$ 51.99 x 1,000
$ 52.02 x 600
-- - --
$ 14.95 - $ 52.00
2,480,366
na
3.71B
$ 1.14
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2022 06-30-2022 10-Q
2 05-10-2022 03-31-2022 10-Q
3 03-01-2022 12-31-2021 10-K
4 11-09-2021 09-30-2021 10-Q
5 08-09-2021 06-30-2021 10-Q
6 05-03-2021 03-31-2021 10-Q
7 03-01-2021 12-31-2020 10-K
8 11-09-2020 09-30-2020 10-Q
9 08-10-2020 06-30-2020 10-Q
10 05-11-2020 03-31-2020 10-Q
11 03-10-2020 12-31-2019 10-K
12 11-04-2019 09-30-2019 10-Q
13 08-05-2019 06-30-2019 10-Q
14 05-06-2019 03-31-2019 10-Q
15 03-11-2019 12-31-2018 10-K
16 11-08-2018 09-30-2018 10-Q
17 08-09-2018 06-30-2018 10-Q
18 05-09-2018 03-31-2018 10-Q
19 03-12-2018 12-31-2017 10-K
20 11-07-2017 09-30-2017 10-Q
21 08-08-2017 06-30-2017 10-Q
22 05-10-2017 03-31-2017 10-Q
23 03-14-2017 12-31-2016 10-K
24 11-08-2016 09-30-2016 10-Q
25 08-09-2016 06-30-2016 10-Q
26 05-10-2016 03-31-2016 10-Q
27 03-14-2016 12-31-2015 10-K
28 11-09-2015 09-30-2015 10-Q
29 08-07-2015 06-30-2015 10-Q
30 05-08-2015 03-31-2015 10-Q
31 03-13-2015 12-31-2014 10-K
32 11-06-2014 09-30-2014 10-Q
33 08-08-2014 06-30-2014 10-Q
34 05-09-2014 03-31-2014 10-Q
35 03-14-2014 12-31-2013 10-K
36 11-12-2013 09-30-2013 10-Q
37 08-13-2013 06-30-2013 10-Q
38 05-14-2013 03-31-2013 10-Q
39 03-14-2013 12-31-2012 10-K
40 11-13-2012 09-30-2012 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

chemocentryxs-return-on-capital-employed-insights
ChemoCentryx's Return On Capital Employed ...
09/01/2022 14:20:27

According to data from Benzinga Pro, during Q2, ChemoCentryx's (NASDAQ:CCXI) reported sales totaled $11.76 million. Despite...

why-jim-cramer-says-this-financial-stock-is-terrific
Why Jim Cramer Says This Financial Stock I...
08/12/2022 12:07:32

On CNBC’s "Mad Money Lightning Round," Jim Cramer said The Charles Schwab Corporation (NYSE: SCHW) is "terrific."

benzingas-top-ratings-upgrades-downgrades-for-august-10-2022
Benzinga's Top Ratings Upgrades, Downgrade...
08/10/2022 14:11:54

 

stifel-downgrades-chemocentryx-to-hold-lowers-price-target-to-52
Stifel Downgrades ChemoCentryx to Hold, Lo...
08/10/2022 11:58:33

Stifel analyst Dae Gon Ha downgrades ChemoCentryx (NASDAQ:CCXI) from Buy to Hold and lowers the price target from $86 to $52.

chemocentryx-q2-earnings-insights
ChemoCentryx: Q2 Earnings Insights
08/09/2022 20:56:18

  ChemoCentryx (NASDAQ:CCXI) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:05 PM. Here's what investo...

chemocentryx-cancels-second-quarter-2022-financial-results-conference-call
ChemoCentryx Cancels Second Quarter 2022 F...
08/09/2022 12:32:38

ChemoCentryx, Inc., (NASDAQ:CCXI), today announced the cancellation of its second quarter 2022 financial results conference cal...

earnings-scheduled-for-august-9-2022
Earnings Scheduled For August 9, 2022
08/09/2022 09:02:37

  Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second q...

earnings-preview-chemocentryx
Earnings Preview: ChemoCentryx
08/08/2022 14:13:58

  ChemoCentryx (NASDAQ:CCXI) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what inves...

where-chemocentryx-stands-with-analysts
Where ChemoCentryx Stands With Analysts
08/05/2022 16:02:23

Over the past 3 months, 4 analysts have published their opinion on ChemoCentryx (NASDAQ:CCXI) stock. These analysts are typical...

benzingas-top-ratings-upgrades-downgrades-for-august-5-2022
Benzinga's Top Ratings Upgrades, Downgrade...
08/05/2022 14:43:02

Upgrades

svb-leerink-downgrades-chemocentryx-to-market-perform-lowers-price-target-to-52
SVB Leerink Downgrades ChemoCentryx to Mar...
08/05/2022 13:59:05

SVB Leerink analyst Joseph Schwartz downgrades ChemoCentryx (NASDAQ:CCXI) from Outperform to Market Perform and lowers the p...

3-analysts-have-this-to-say-about-chemocentryx
3 Analysts Have This to Say About ChemoCen...
08/05/2022 13:48:47

ChemoCentryx (NASDAQ:CCXI) has observed the following analyst ratings within the last quarter:

hc-wainwright--co-downgrades-chemocentryx-to-neutral-lowers-price-target-to-52
HC Wainwright & Co. Downgrades ChemoCentry...
08/05/2022 10:59:30

HC Wainwright & Co. analyst Edward White downgrades ChemoCentryx (NASDAQ:CCXI) from Buy to Neutral and lowers the price ...

canaccord-genuity-downgrades-chemocentryx-to-hold-announces-52-price-target
Canaccord Genuity Downgrades ChemoCentryx ...
08/05/2022 10:14:26

Canaccord Genuity analyst Edward Nash downgrades ChemoCentryx (NASDAQ:CCXI) from Buy to Hold and announces $52 price target.

why-nanoviricides-jumped-over-48-here-are-106-biggest-movers-from-yesterday
Why NanoViricides Jumped Over 48%; Here Ar...
08/05/2022 10:12:59

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, annou...

raymond-james-downgrades-chemocentryx-to-market-perform
Raymond James Downgrades ChemoCentryx to M...
08/05/2022 08:37:39

Raymond James analyst Steven Seedhouse downgrades ChemoCentryx (NASDAQ:CCXI) from Strong Buy to Market Perform.

coinbase-mercadolibre-and-some-other-big-stocks-recording-gains-on-thursday
Coinbase, MercadoLibre And Some Other Big ...
08/05/2022 08:00:47

U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks m...

gold-tops-1800-alibaba-reports-upbeat-results
Gold Tops 1,800; Alibaba Reports Upbeat Re...
08/04/2022 18:48:56

U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 75 points on Thursday

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
08/04/2022 18:06:58

 

why-chemocentryx-is-trading-higher-by-110-here-are-95-stocks-moving-in-thursdays-mid-day-session
Why ChemoCentryx Is Trading Higher By 110%...
08/04/2022 17:12:21

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION